Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS).

Melmer, Andreas; Züger, Thomas; Lewis, Dana M; Leibrand, Scott; Stettler, Christoph; Laimer, Markus (2019). Glycaemic control in individuals with type 1 diabetes using an open source artificial pancreas system (OpenAPS). Diabetes, obesity & metabolism, 21(10), pp. 2333-2337. Wiley 10.1111/dom.13810

[img] Text
Melmer_et_al-2019-Diabetes,_Obesity_and_Metabolism.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (375kB)

Open source artificial pancreas systems (OpenAPS) have gained considerable interest in the diabetes community. We analyzed continuous glucose monitoring (CGM) records of 80 OpenAPS users with type 1 diabetes (T1D). A total of 19 495 days (53.4 years) of CGM records were available. Mean glucose was 7.6 ± 1.1 mmol/L, time in range 3.9-10 mmol/L was 77.5 ± 10.5%, <3.9 mmol/L was 4.3 ± 3.6%, <3.0 mmol/L was 1.3 ± 1.9%, >10 mmol/L was 18.2 ± 11.0% and > 13.9 mmol/L was 4.1 ± 4.0%, respectively. In 34 OpenAPS users, additional CGM records were obtained while using sensor-augmented pump therapy (SAP). After changing from SAP to OpenAPS, lower mean glucose (-0.6 ± 0.7; P < 0.0001), lower estimated HbA1c (-0.4 ± 0.5%; P < 0.0001), higher time in range 3.9-10 mmol/L (+9.3 ± 9.5%; P < 0.0001), less time < 3.0 mmol/L (-0.7 ± 2.2%; P = 0.0171), lower coefficient of variation (-2.4 ± 5.8; P = 0.0198) and lower mean of daily differences (-0.6 ± 0.9 mmol/L; P = 0.0005) was observed. Glycaemic control using OpenAPS was comparable with results of more rigorously developed and tested AP systems. However, OpenAPS was used by a highly selective, motivated and technology-adept cohort, despite not being approved for the treatment of individuals with T1D.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Melmer, Andreas, Züger, Thomas Johannes, Stettler, Christoph, Laimer, Markus

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1463-1326

Publisher:

Wiley

Language:

English

Submitter:

Markus Laimer

Date Deposited:

18 Sep 2019 16:47

Last Modified:

05 Dec 2022 15:30

Publisher DOI:

10.1111/dom.13810

PubMed ID:

31183929

Uncontrolled Keywords:

artificial pancreas glycaemic control glycaemic variability open source type 1 diabetes

BORIS DOI:

10.7892/boris.133295

URI:

https://boris.unibe.ch/id/eprint/133295

Actions (login required)

Edit item Edit item
Provide Feedback